7-130299321-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016352.4(CPA4):c.202G>A(p.Val68Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016352.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA4 | NM_016352.4 | c.202G>A | p.Val68Ile | missense_variant | 3/11 | ENST00000222482.10 | NP_057436.2 | |
CPA4 | NM_001163446.2 | c.202G>A | p.Val68Ile | missense_variant | 3/10 | NP_001156918.1 | ||
CPA4 | XM_047420438.1 | c.-111G>A | 5_prime_UTR_variant | 3/11 | XP_047276394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA4 | ENST00000222482.10 | c.202G>A | p.Val68Ile | missense_variant | 3/11 | 1 | NM_016352.4 | ENSP00000222482.4 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251466Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135906
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461072Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 726882
GnomAD4 genome AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The c.202G>A (p.V68I) alteration is located in exon 3 (coding exon 3) of the CPA4 gene. This alteration results from a G to A substitution at nucleotide position 202, causing the valine (V) at amino acid position 68 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at